Sequencing additional genes known to be associated with leukemogenesis in CN (e.g., RUNX1) might help to identify early stages of malignant transformation and could have a decisive role in guiding clinical decisions. The gene discussed is RUNX1; the disease is cyclic hematopoiesis.